Our Sites » TechNews TechDatabase Canadian Private Equity Register     Login

Home » Divestitures » Angiotech Pharmaceuticals Sells Quill to Johnson & Johnson

Angiotech Pharmaceuticals Sells Quill to Johnson & Johnson

Angiotech Pharmaceuticals, Inc. (TSX: ANP; NASDAQ: ANPI) has sold certain Quill intellectual property to Ethicon, Inc., a unit of Johnson & Johnson, Inc., and its affiliates. Angiotech will receive initial cash payment... 

To Read This Article, please Login





See Also:

Copyright © 2013 TechFinance.ca. All rights reserved. | Healthy Living | wp-tips.
More in Divestitures (10 of 71 articles)


...